• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Am J Cardiol . Impact and Determinants of High-Sensitivity Cardiac Troponin-T Concentration in Patients With COVID-19 Admitted to Critical Care

tetano

Editor, Senior Moderator
Am J Cardiol


. 2021 Feb 19;S0002-9149(21)00148-X.
doi: 10.1016/j.amjcard.2021.01.037. Online ahead of print.
Impact and Determinants of High-Sensitivity Cardiac Troponin-T Concentration in Patients With COVID-19 Admitted to Critical Care


Ozan M Demir[SUP] 1 [/SUP], Matthew Ryan[SUP] 1 [/SUP], Chiara Cirillo[SUP] 2 [/SUP], Nishita Desai[SUP] 3 [/SUP], Ana Pericao[SUP] 3 [/SUP], Hannah Sinclair[SUP] 3 [/SUP], Vasileios Stylianidis[SUP] 3 [/SUP], Kelly Victor[SUP] 3 [/SUP], Bashir Alaour[SUP] 1 [/SUP], Andrew Jones[SUP] 3 [/SUP], Antonis N Pavlidis[SUP] 3 [/SUP], Andrew Retter[SUP] 3 [/SUP], Gerald Carr-White[SUP] 4 [/SUP], Luigi Camporota[SUP] 3 [/SUP], Nicholas Barrett[SUP] 3 [/SUP], Michael Marber[SUP] 1 [/SUP], Divaka Perera[SUP] 5 [/SUP]



Affiliations

Abstract

Cardiac Troponin (hs-TnT) elevation has been reported in unselected patients hospitalised with COVID-19 however the mechanism and relationship with mortality remain unclear. Consecutive patients admitted to a high-volume intensive care unit (ICU) in London with severe COVID-19 pneumonitis were included if hs-TnT concentration at admission was known. Kaplan-Meier survival analysis performed, with cohorts classified a priori by multiples of the upper limit of normal (ULN). 277 patients were admitted during a 7-week period in 2020; 176 were included (90% received invasive ventilation). hs-TnT at admission was 16.5 (9.0-49.3) ng/L, 56% had concentrations >ULN. 56 patients (31.8%) died during the index admission. Admission hs-TnT level was lower in survivors (12.0 (8.0-27.8) vs 28.5 (14.0-81.0) ng/L, p=0.001). Univariate predictors of mortality were age, APACHE-II Score and admission hs-TnT (HR 1.73, p=0.007). By multivariate regression, only age (HR 1.33, CI: 1.16.-1.51, p<0.01) and admission hs-TnT (HR 1.94, CI: 1.22-3.10, p=0.006) remained predictive. Survival was significantly lower when admission hs-TnT was >ULN (log-rank p-value<0.001). Peak hs-TnT was higher in those who died but was not predictive of death after adjustment for other factors. In conclusion, In critically ill patients with COVID-19 pneumonitis, the hs-TnT level at admission is a powerful independent predictor of the likelihood of surviving to discharge from ICU. In most cases, hs-TnT elevation does not represent major myocardial injury but acts as a sensitive integrated biomarker of global stress. Whether stratification based on admission Troponin level could be used to guide prognostication and management warrants further evaluation.

Keywords: biomarkers; coronavirus; intensive care unit; severe acute respiratory syndrome coronavirus 2.
 
Back
Top Bottom